Potential Therapeutic Strategy for EGFR-Mutant Lung Cancer With Concomitant EML4-ALK Rearrangement-Combination of EGFR Tyrosine Kinase Inhibitors and ALK Inhibitors.

EGFR突变肺癌伴EML4-ALK重排的潜在治疗策略——EGFR酪氨酸激酶抑制剂和ALK抑制剂的联合治疗